Primary Care Pod podcast

New(ish) Drug for MACE Prevention

0:00
15:30
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention).  NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.

 

 

Altri episodi di "Primary Care Pod"